TELA Bio, Inc.: cashflow_financing
| Value | {"amount": -298000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-03-31 |
| Status | current |
| Entity | TELA Bio, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:52:15.364627+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/213c9e77-15b5-4a10-9374-f85e4dfd35bf
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-26-060234Retrieved: 2026-08-19T15:52:15.364627+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001561921/cashflow-financing/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/213c9e77-15b5-4a10-9374-f85e4dfd35bf
History
- no predecessors — first report